Company Filing History:
Years Active: 2002-2016
Title: Innovations by Anthony Dorling
Introduction
Anthony Dorling is a notable inventor based in London, GB, recognized for his contributions to the field of biomedical innovations. With a total of six patents to his name, he has made significant strides in the development of anticoagulant therapies that aim to improve patient outcomes during organ transplantation.
Latest Patents
One of his latest patents is focused on an anticoagulant fusion protein anchored to the cell membrane. This invention addresses the inhibition of blood coagulation, particularly during organ rejection. The technology involves anticoagulant proteins that are anchored to cell membranes, with the anticoagulant function being provided by agents such as heparin, antithrombin, and hirudin. These proteins are designed to be regulated according to cell activation, thereby rendering cells, tissues, and organs less vulnerable to rejection after transplantation.
Another significant patent by Dorling is for antithrombotic compounds. This soluble compound is aimed at preventing or reducing blood coagulation and comprises an antithrombotic agent along with a membrane binding element. The compounds can be utilized in therapeutic applications, particularly in the context of organ perfusion to prevent or reduce blood coagulation.
Career Highlights
Throughout his career, Anthony Dorling has worked with esteemed organizations such as Imperial College Innovations Limited and Imperial Innovations Limited. His work has been pivotal in advancing the understanding and treatment of blood coagulation disorders.
Collaborations
Dorling has collaborated with notable professionals in his field, including Robert Ian Lechler and Kristian Riesbeck. These collaborations have contributed to the development of innovative solutions in the biomedical sector.
Conclusion
Anthony Dorling's contributions to the field of biomedical innovations, particularly in anticoagulant therapies, highlight his role as a significant inventor. His work continues to influence advancements in medical treatments and organ transplantation.